oxycodone has been researched along with esketamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brinck, ECV; Kankare, J; Kontinen, VK; Maisniemi, K; Tarkkila, P; Tielinen, L | 1 |
| Brinck, ECV; Hynninen, VV; Kontinen, V; Liukas, A; Maisniemi, K; Mäkelä, S; Mulo, J; Olkkola, KT; Peltoniemi, M; Rantakokko, J; Saari, TI; Savolainen, U; Soini, V; Tarkkila, P; Virtanen, T | 1 |
2 trial(s) available for oxycodone and esketamine
| Article | Year |
|---|---|
Analgesic Effect of Intraoperative Intravenous S-Ketamine in Opioid-Naïve Patients After Major Lumbar Fusion Surgery Is Temporary and Not Dose-Dependent: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Intraoperative Care; Ketamine; Lumbar Vertebrae; Male; Middle Aged; Oxycodone; Pain, Postoperative; Prospective Studies; Spinal Fusion; Time Factors; Treatment Outcome | 2021 |
S-ketamine in patient-controlled analgesia reduces opioid consumption in a dose-dependent manner after major lumbar fusion surgery: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ketamine; Lumbar Vertebrae; Lumbosacral Region; Male; Middle Aged; Outcome Assessment, Health Care; Oxycodone; Pain Measurement; Pain, Postoperative; Spinal Fusion | 2021 |